Results 191 to 200 of about 123,523 (307)

Inactivation of AXL in Cardiac Fibroblasts Alleviates Right Ventricular Remodeling in Pulmonary Hypertension. [PDF]

Adv Sci (Weinh)
Wu LW, Chen M, Jiang CY, Jiang DJ, Zhang X, Xu XH, Liu YW, Feng B, Ye LC, He YY, Huang X, Zhang YC, Zhou XL, Shen Y, Liu TY, Fu LJ, Yan Y, Zhang H.   +17 more
europepmc   +1 more source

Lean ZSF1 rats in basic research on heart failure with preserved ejection fraction

ESC Heart Failure, Volume 12, Issue 2, Page 1474-1478, April 2025.
Abstract Aims ZSF1 obese rats harbouring two mutant leptin receptor alleles (Leprcp and Leprfa) develop metabolic syndrome and heart failure with preserved ejection fraction (HFpEF), making them a widely used animal model in cardiometabolic research.
Petra Büttner, Antje Augstein, Mahmoud Abdellatif, André Lourenço, Adelino Leite‐Moreira, Inês Falcão‐Pires, Sarah Werner, Holger Thiele, Simon Sedej, Antje Schauer, Volker Adams   +10 more
wiley   +1 more source

Heart rate and left ventricular remodeling after repaired coarctation of the aorta: a cross-sectional study.

Clin Hypertens
Vaccari M, Maldonado LE, Moros CG, Sardella A, Romo M, Romero CA, ARECO Study Group.   +6 more
europepmc   +1 more source

Effects of epigallocatechin-3-gallate on left ventricular remodeling and functional recovery following aortic coarctation surgery. [PDF]

BMC Cardiovasc Disord
Yu S, Luo M, Tian J, Liu L.
europepmc   +1 more source

Interventional therapies for chronic heart failure: An overview of recent developments

ESC Heart Failure, Volume 12, Issue 2, Page 1081-1094, April 2025.
Abstract Heart failure (HF), the final manifestation of most cardiovascular diseases, has become a major global health concern, affecting millions of individuals. Despite basic drug treatments, patients present with high morbidity and mortality rates. However, recent advancements in interventional therapy have shown promising results in improving the ...
Bingchen Guo, Si Shi, Yutong Guo, Jie Xiong, Bo Wang, Zengxiang Dong, Dianyu Gao, Yingfeng Tu   +7 more
wiley   +1 more source

Therapeutic Impact of Vericiguat on Ventricular Remodeling in a Pressure-Overload Heart Failure Model. [PDF]

Life (Basel)
Hao WR, Chen CC, Li FA, Chen HY, Liu JC, Cheng TH, Chen JJ.   +6 more
europepmc   +1 more source

Left ventricular diastolic dysfunction worsens prognosis in patients with heart failure due to dilated cardiomyopathy

ESC Heart Failure, Volume 12, Issue 2, Page 1183-1193, April 2025.
Abstract Aims The prognostic significance of left ventricular (LV) diastolic dysfunction (LVDD) severity in patients with dilated cardiomyopathy (DCM) remains uncertain. This study aimed to evaluate the association of LVDD severity and elevated left atrial pressure (eLAP) with patient outcomes in stable, non‐acutely decompensated patients with DCM ...
Mateusz Winiarczyk, Ewa Dziewięcka, Sylwia Wiśniowska‐Śmiałek, Agnieszka Stępień, Katarzyna Graczyk, Agata Leśniak‐Sobelga, Marta Hlawaty, Jakub Woźniak, Maryia Savitskaya, Katarzyna Holcman, Magdalena Kostkiewicz, Piotr Podolec, Paweł Rubiś   +12 more
wiley   +1 more source

Ovarian hormones attenuate right ventricular remodeling in a rat model of pulmonary arterial hypertension. [PDF]

Biomech Model Mechanobiol
Hardie BA, Huberts J, Bennington M, Valdez-Jasso D.   +3 more
europepmc   +1 more source

PRP-loaded pH-responsive hydrogel for the amelioration of ventricular remodeling following myocardial infarction. [PDF]

Mater Today Bio
Liu JE, Cheng Z, Zhao P, Wu Y, Zhu L, Yu C, Zhou W, Wang T, Cheng X, Dong Q, Bao H.   +10 more
europepmc   +1 more source

Transendocardial injection of expanded autologous CD34+ cells after myocardial infarction: Design of the EXCELLENT trial

ESC Heart Failure, Volume 12, Issue 2, Page 1455-1463, April 2025.
Abstract Aims The extent of irreversible cardiomyocyte necrosis after acute myocardial infarction (AMI) is a major determinant of residual left ventricular (LV) function and clinical outcome. Cell therapy based on CD34+ cells has emerged as an option to help repair the myocardium and to improve outcomes.
Jerome Roncalli, François Roubille, Nicolas Meyer, Giulio Pompilio, Lionel Leroux, Philippe Henon, Guillaume Trebuchet, Anthony Criquet, Matthieu de Kalbermatten, Eric Saloux, Alain Manrique, Pierre‐Yves Marie, Deepak L. Bhatt, Scott D. Solomon, Gilles Montalescot, David E. Newby, Faiez Zannad, on behalf of the EXCELLENT Trial Investigators   +17 more
wiley   +1 more source